Close

Monopar Partners with Seasoned Medtech Executive to Explore the Potential of MNPR-101 as a uPAR Imaging Agent in Cancer Surgery

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. UAL
5. CSX
6. BPTS
7. EFX
8. ORCL
9. TSLA
10. INFY


Go back to Monopar Partners with Seasoned Medtech Executive to Explore the Potential of MNPR-101 as a uPAR Imaging Agent in Cancer Surgery
(NASDAQ: MNPR) Delayed: 0.71 +0.06 (9.23%)
Previous Close $0.65    52 Week High $ 
Open $0.70    52 Week Low $ 
Day High $0.72    P/E N/A 
Day Low $0.66    EPS $ 
Volume 37,635